Skip to main content
HR 2676 110th Congress House Health Cancer Civil Rights and Liberties, Minority Issues Clinical trials Collective bargaining Commerce Congressional reporting requirements Cost accounting Discrimination in insurance Discrimination in medical care Employee health benefits Finance and Financial Sector Health insurance Labor and Employment Labor contracts Medical economics Medical fees Medical research Patients' rights Peer review organizations (Medicine)

Access to Cancer Clinical Trials Act of 2007

Introduced: June 12, 2007 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 24, 2007
Referred to the Subcommittee on Health, Employment, Labor, and Pensions.
Jun 18, 2007
Referred to the Subcommittee on Health.
Jun 12, 2007
Referred to the Subcommittee on Health.
Jun 12, 2007
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Labor, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 12, 2007
Introduced in House
 Plain-English summary Congressional Research Service

Access to Cancer Clinical Trials Act of 2007 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to prohibit a group health plan from: (1) denying an eligible participant or beneficiary participation in clinical trials related to the treatment of cancer that are federally funded or conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); (2) denying (or limiting or imposing additional conditions on) the coverage of routine patient costs for items and services furnished in connection with such participation; or (3) discriminating against an individual on the basis of such participation. Includes as routine patient costs all items and services provided in the clinical trial that are otherwise generally available to a qualified individual, with certain exceptions.

Applies such prohibitions to coverage offered in the individual market.

Requires the Secretary of Health and Human Services to study the impact on group health plans and health insurance issuers of requiring them to cover routine patient care costs for individuals with serious and life threatening diseases other than cancer.

What's happening now July 24, 2007

Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

 Committees of jurisdiction 6
 Cosponsors 5
All 5 Democratic 5